Reducing Pharmaceutical Prices Requires Competition, Not Price-Fixing
May 20, 2025 / /
[ad_1]

Cutting the red tape around biosimilars is one way that the administration can protect U.S. drug innovation and make medicine more affordable for Americans.
[ad_2]
Source link
Posted in Politics